| Authors: |
Linossi EM; Cardiovascular Research Institute, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Estevam GO; Department of Bioengineering and Therapeutic Sciences, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Oshima M; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA 94158, U.S.A.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Fraser JS; Department of Bioengineering and Therapeutic Sciences, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Collisson EA; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA 94158, U.S.A.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Jura N; Cardiovascular Research Institute, University of California - San Francisco, San Francisco, CA 94158, U.S.A.; Department of Cellular and Molecular Pharmacology, University of California - San Francisco, San Francisco, CA 94158, U.S.A. |
